Drug Product Quality Dashboard Taking Shape at FDA in Wake of OPQ Integration and Expanding Knowledge Base
Jan 31st, 2016
Please Log in to print the full article
OPQ, she said, is now actively working on developing a “unified risk evaluation framework for brand and generic drugs that integrates the structured risk assessments with the existing drug product knowledge base that we are...
You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.